Search

Your search keyword '"Patterson, Jillian A."' showing total 10 results
Start Over Author "Patterson, Jillian A." Language undetermined
10 results on '"Patterson, Jillian A."'

1. Additional file 1 of Validation of anaemia, haemorrhage and blood disorder reporting in hospital data in New South Wales, Australia

Author

Baldwin, Heather J., Nippita, Tanya A., Siranda Torvaldsen, McGee, Therese M., Rickard, Kristen, and Patterson, Jillian A.

Abstract

Additional file 1: Table 1. International Classification of Diseases, Tenth Edition, Australian Modification (ICD-10-AM) diagnostic and Australian Classification of Health Interventions, Eighth Edition (ACHI) procedure codes for anaemia and bleeding disorders used in this study. Table 2. Rates of diagnoses and procedures identified by hospital and data source, New South Wales, 2011-2015.

Published
2021
Full Text
View/download PDF

10. Incidence of metastatic breast cancer in an Australian population‐based cohort of women with non‐metastatic breast cancer at diagnosis

Author

David Roder, Val Gebski, Sarah J. Lord, Belinda E Kiely, Jillian A. Patterson, Sally Crossing, Nehmat Houssami, Nicholas Wilcken, Melina Gattellari, M. Luke Marinovich, Lord, Sarah J, Marinovich, M Luke, Patterson, Jillian A, Wilcken, Nicholas, Kiely, Belinda E, Gebski, Val, Crossing, Sally, Roder, David M, Gattellari, Melinda, and Houssami, Nehmat

Subjects
Oncology, medicine.medical_specialty, education.field_of_study, diagnosis, business.industry, Incidence (epidemiology), Population, Australia, Cancer, General Medicine, medicine.disease, Metastatic breast cancer, breast cancer, Breast cancer, Internal medicine, Epidemiology of cancer, medicine, Cumulative incidence, skin and connective tissue diseases, business, education, Cohort study
Abstract

Objectives: To estimate the incidence of metastatic breast cancer (MBC) in Australian women with an initial diagnosis of non-metastatic breast cancer. Design, setting and participants: A population-based cohort study of all women with non-metastatic breast cancer registered on the New South Wales Central Cancer Register (CCR) in 2001 and 2002 who received care in a NSW hospital. Main outcome measures: 5-year cumulative incidence of MBC; prognostic factors for MBC. Results: MBC was recorded within 5 years in 218 of 4137 women with localised node-negative disease (5-year cumulative incidence, 5.3%; 95% CI, 4.6%–6.0%); and 455 of 2507 women with regional disease (5-year cumulative incidence, 18.1%; 95% CI, 16.7%–19.7%). The hazard rate for developing MBC was highest in the second year after the initial diagnosis of breast cancer. Determinants of increased risk of MBC were regional disease at diagnosis, age less than 50 years and living in an area of lower socio-economic status. Conclusions: Our Australian population-based estimates are valuable when communicating average MBC risks to patients and planning clinical services and trials. Women with node-negative disease have a low risk of developing MBC, consistent with outcomes of adjuvant clinical trials. Regional disease at diagnosis remains an important prognostic factor. Refereed/Peer-reviewed

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results